Amphastar Pharmaceuticals Inc

NASDAQ:AMPH   3:59:55 PM EDT
19.97
+0.41 (+2.10%)
Products

FDA Approves First Generic Of Drug Used To Treat Severe Hypoglycemia

Published: 12/28/2020 23:39 GMT
Amphastar Pharmaceuticals Inc (AMPH) - FDA - Approves First Generic of Drug Used to Treat Severe Hypoglycemia.
FDA - FDA Granted Approval of This Generic Glucagon for Injection to Amphastar Pharmaceuticals, Inc. of Rancho Cucamonga, Calif.